Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study

Background Evidence on renin–angiotensin system inhibitors (RASis) effect in reducing urinary protein levels in patients with nephrotic syndrome is insufficient. We determined whether RASis can induce complete remission (CR) in patients on immunosuppressive therapy. Methods This cohort study include...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental nephrology 2023-05, Vol.27 (5), p.480-489
Hauptverfasser:	Shimizu, Sayaka, Niihata, Kakuya, Nishiwaki, Hiroki, Shibagaki, Yugo, Yamamoto, Ryohei, Nitta, Kosaku, Tsukamoto, Tatsuo, Uchida, Shunya, Takeda, Asami, Okada, Hirokazu, Narita, Ichiei, Isaka, Yoshitaka, Kurita, Noriaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angiotensin Antihypertensive Agents Biopsy Cohort analysis Cohort Studies Enzyme Inhibitors - pharmacology Glomerulonephritis, Membranous - pathology Humans Immunosuppressive agents Immunosuppressive Agents - pharmacology Immunosuppressive Agents - therapeutic use Kidney diseases Male Medicine Medicine & Public Health Membranous nephropathy Nephrology Nephropathy Nephrotic syndrome Nephrotic Syndrome - complications Original Article Regression analysis Remission Renin Renin-Angiotensin System Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!